Details of the Drug Formulations

General Information of Drug (ID: DM70BU5)

• Drug Name: Thalidomide Drug Info
• Synonyms: Algosediv; Asmadion; Asmaval; Bonbrain; Bonbrrin; Calmore; Calmorex; Contergan; Corronarobetin; Distaval; Distaxal; Distoval; Ectiluran; Enterosediv; Gastrinide; Glupan; Glutanon; Grippex; Hippuzon; Imidene; Isomin; Kedavon; Kevadon; Neaufatin; Neosedyn; Neosydyn; Nerosedyn; Neufatin; Neurodyn; Neurosedin; Neurosedym; Neurosedyn; Nevrodyn; Nibrol; Noctosediv; Noxodyn; Pangul; Pantosediv; Polygripan; Profarmil; Psycholiquid; Psychotablets; Quetimid; Quietoplex; Sandormin; Sedalis; Sedimide; Sedin; Sedisperil; Sedoval; Shinnibrol; Sleepan; Slipro; Softenil; Softenon; Synovir; Talargan; Talidomida; Talidomide; Talimol; Talismol; Talizer; Telagan; Telargan; Telargean; Tensival; Thaled; Thalidomidum; Thalin; Thalinette; Thalomid; Thalomide; Theophilcholine; Valgis; Valgraine; Yodomin; Celgene Brand of Thalidomide; Talidomide [DCIT]; Thalidomide Celgene; Thalidomide Pharmion; Asidon 3; ENMD 0995; IN1061; Thalidomine USP26; Alpha-Phthalimidoglutarimide; E-217; Imida-lab; Imidan (peyta); N-Phthalimidoglutamic acid imide; N-Phthaloylglutamimide; N-Phthalylglutamic acid imide; Poly-Giron; Predni-Sediv; Pro-Bam M; Pro-ban M; Sedalis sedi-lab; Shin-naito S; THALIDOMIDE (AIDS INITIATIVE); Talidomida [INN-Spanish]; Thaled (TN); Thalidomide (soluble form); Thalidomidum [INN-Latin]; Thalomid (TM); Thalomid (TN); Thalomid, Thalidomide; Alpha-N-Phthalylglutaramide; Thalidomide [USAN:INN:BAN]; Alpha-(N-Phthalimido)glutarimide; N-Phthalyl-glutaminsaeure-imid; N-Phthalyl-glutaminsaeure-imid [German]; Thalidomide (+ and-); Thalidomide (JAN/USP/INN); N-(2,6-Dioxo-3-piperidyl)phthalimide; (+)-Thalidomide; (+-)-Thalidomide; (+/-)-THALIDOMIDE; (inverted question mark)-Thalidomide; 2,6-Dioxo-3-phthalimidopiperidine; 3-Phthalimidoglutarimide

Indication

Disease Entry	ICD 11	Status	REF
Adult T-cell leukemia/lymphoma		Approved	[1]
Advanced cancer	2A00-2F9Z	Approved	[1]
Complex regional pain syndrome type 1		Approved	[1]
Hepatosplenic T-cell lymphoma		Approved	[1]
Large granular lymphocytic leukemia	2A90.1	Approved	[1]
Leukemia		Approved	[1]
MALT lymphoma		Approved	[1]
Multiple myeloma	2A83	Approved	[2]
Nodal marginal zone lymphoma	2A85.0	Approved	[1]
Pain	MG30-MG3Z	Approved	[1]
Plasma cell myeloma	2A83.1	Approved	[1]
Primary cutaneous peripheral T-cell lymphoma not otherwise specified		Approved	[1]
Prolymphocytic leukaemia	2A82.1	Approved	[1]
Recurrent adult burkitt lymphoma	2A85.6	Approved	[1]
Small intestine lymphoma		Approved	[1]
Splenic marginal zone lymphoma		Approved	[1]
Testicular lymphoma		Approved	[1]
Urinary bladder neoplasm		Approved	[1]
Waldenstrom macroglobulinemia	2A85.4	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[3]
Colon cancer	2B90.Z	Investigative	[1]

• Therapeutic Class: Immunosuppressive Agents
• Cross-matching ID:
  PubChem CID: 5426
  ChEBI ID: CHEBI:74947
  CAS Number: 50-35-1
  TTD ID: D0U7GK
  VARIDT ID: DR00461
  INTEDE ID: DR1572
  ACDINA ID: D00669

Full List of Drug Formulations Containing This Drug

Thalidomide 100 mg capsule

Company	Formulation ID	FDA Description
Celgene Corporation	F21030	Magnesium stearate; Starch, corn

Thalidomide 150 mg capsule

Company	Formulation ID	FDA Description
Celgene Corporation	F21031	Magnesium stearate; Starch, corn

Thalidomide 200 mg capsule

Company	Formulation ID	FDA Description
Celgene Corporation	F21032	Magnesium stearate; Starch, corn

Thalidomide 50 mg capsule

Company	Formulation ID	FDA Description
Celgene Corporation	F21033	Magnesium stearate; Starch, corn

References

• [1] Thalidomide FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7327).
• [3] ClinicalTrials.gov (NCT04273529) The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia. U.S. National Institutes of Health.